Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Multiple Ascending Dose and DDI Study
- Status
- COMPLETED
- Phase
- PHASE1
Improving Value of Care for Patients With Severe Stasis Dermatitis
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease
- Status
- WITHDRAWN
- Phase
- PHASE4
Safety and Tolerability of PF-06818883 in Healthy Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-
- Status
- COMPLETED
- Phase
- N/A
Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis
- Status
- COMPLETED
- Phase
- PHASE1
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
- Status
- COMPLETED
- Phase
- NA
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Opportunistic Screening in Pharmacies for Atrial Fibrillation in Seniors (>65 Years)
- Status
- COMPLETED
- Phase
- N/A
Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation
- Status
- WITHDRAWN
- Phase
- N/A
Study of Tofacitinib in Refractory Dermatomyositis
- Status
- COMPLETED
- Phase
- PHASE1
A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA
- Status
- COMPLETED
- Phase
- PHASE3
An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label Pharmacokinetics and Safety Study of Talazoparib
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate
- Status
- COMPLETED
- Phase
- PHASE2
Korean Post-marketing Surveillance for Xeljanz
- Status
- COMPLETED
- Phase
- N/A
A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
- Status
- COMPLETED
- Phase
- PHASE2